JPRN-UMIN000019455已完成未知
Study of the Influenza vaccine immune response using PMMA dialyzer. - Influenza vaccine effectiveness in using PMMA dialyzer
Oita University Hospital Blood purification center0 个研究点目标入组 120 人开始时间: 2015年10月26日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •A patient who is judged as the inadequate subject of this study by the doctor.
研究者
相似试验
已完成
不适用
Study of the Influenza vaccine immune response using PMMA dialyzer.End-stage renal disease requiring hemodialysisJPRN-UMIN000015853Oita naika clinic50
进行中（未招募）
1 期
Evaluation of how body's defense system against infection responds to the flu vaccine in cancer patients being treated with idelalisibTo assess the immune response to an influenza vaccine in subjects with B-cell malignancies treated with idelalisibMedDRA version: 20.0 Level: PT Classification code 10065856 Term: Non-Hodgkin's lymphoma unspecified histology indolent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-003055-30-ESGilead Sciences, Inc.22
进行中（未招募）
1 期
Evaluation of how body's defense system against infection responds to the flu vaccine in cancer patients being treated with idelalisibTo assess the immune response to an influenza vaccine in subjects with B-cell malignancies treated with idelalisibMedDRA version: 20.0 Level: PT Classification code 10065856 Term: Non-Hodgkin's lymphoma unspecified histology indolent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-003055-30-CZGilead Sciences, Inc.22
进行中（未招募）
1 期
Evaluation of how body's defense system against infection responds to the flu vaccine in cancer patients being treated with idelalisibEUCTR2017-003055-30-PLGilead Sciences, Inc.22
进行中（未招募）
1 期
Evaluation of how body's defense system against infection responds to the flu vaccine in cancer patients being treated with idelalisibEUCTR2017-003055-30-FRGilead Sciences, Inc.22